Status:
COMPLETED
Seborrheic Dermatitis: Ketoconazole 2% Foam Versus Ketoconazole 2% Shampoo
Lead Sponsor:
St. Louis University
Conditions:
Seborrheic Dermatitis
Eligibility:
FEMALE
18-89 years
Phase:
NA
Brief Summary
The aims of this study are to compare the effectiveness of antifungal foam versus antifungal shampoo and determine patient compliance and satisfaction with both vehicles among African American females...
Detailed Description
A wide variety of topical vehicles are available for medications that treat scalp disorders. Proper vehicle selection is important when managing scalp conditions, such as seborrheic dermatitis, becaus...
Eligibility Criteria
Inclusion
- African American females aged 18 to 89 years
- Previous diagnosis of seborrheic dermatitis of the scalp
- TDSS between 50 and 200
- Practice less than or equal to once weekly hair washing
- Immunocompetent
- Willing to not grease or oil scalp
Exclusion
- Age below 18 years or above 89 years
- Medical history of psoriasis, diabetes mellitus, immunosuppression, neurologic disorders, and/or chronic disease not stabilized by medication
- Patients taking any oral steroids and/or antifungals within 30 days of enrollment
- Sensitivity to any formulation components of either ketoconazole foam or shampoo including sulfur
- The use of any topical medications including over the counter products indicated for the treatment of seborrheic dermatitis within 14 days of enrollment
- Pregnant women, women who plan on becoming pregnant, or breastfeeding women
- Current use or history of using any biologic medication
Key Trial Info
Start Date :
September 1 2010
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
June 1 2013
Estimated Enrollment :
23 Patients enrolled
Trial Details
Trial ID
NCT01203189
Start Date
September 1 2010
End Date
June 1 2013
Last Update
November 6 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
St. Louis University Department of Dermatology
St Louis, Missouri, United States, 63104